Alliancebernstein L.P. Intercept Pharmaceuticals, Inc. Put Options Transaction History

Alliancebernstein L.P.

1 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q1 2018 May 14, 2018	BUY	$52.72 - $67.25 $2.11 Million - $2.69 Million	40,000 New	40,000 $2.46 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.